Letter to CMS Supporting Proposed Decision to Severely Restrict Coverage for β-Amyloid PET Imaging in Dementia
July 23, 2013
View as PDF.
Public Citizen strongly supports the Centers for Medicare & Medicaid Services’ (CMS’s) proposed decision to only cover positron emission tomography (PET) amyloid-beta (Aβ) imaging in dementia and neurodegenerative disease for a limited set of circumstances. There is insufficient clinical-trial data to support that this technology changes the health outcomes of patients who display early symptoms or signs of cognitive dysfunction, or in any other patient population.